Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease - PubMed (original) (raw)
Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease
Stefanie Joos et al. BMC Complement Altern Med. 2006.
Abstract
Background: Previous studies have suggested an increasing use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD). The aim of our study was to evaluate the use of CAM in German patients with IBD.
Methods: A questionnaire was offered to IBD patients participating in patient workshops which were organized by a self-help association, the German Crohn's and Colitis Association. The self-administered questionnaire included demographic and disease-related data as well as items analysing the extent of CAM use and satisfaction with CAM treatment. Seven commonly used CAM methods were predetermined on the questionnaire.
Results: 413 questionnaires were completed and included in the analysis (n = 153 male, n = 260 female; n = 246 Crohn's disease, n = 164 ulcerative colitis). 52 % of the patients reported CAM use in the present or past. In detail, homeopathy (55%), probiotics (43%), classical naturopathy (38%), Boswellia serrata extracts (36%) and acupuncture/Traditional Chinese Medicine (TCM) (33%) were the most frequently used CAM methods. Patients using probiotics, acupuncture and Boswellia serrata extracts (incense) reported more positive therapeutic effects than others. Within the statistical analysis no significant predictors for CAM use were found. 77% of the patients felt insufficiently informed about CAM.
Conclusion: The use of CAM in IBD patients is very common in Germany, although a large proportion of patients felt that information about CAM is not sufficient. However, to provide an evidence-based approach more research in this field is desperately needed. Therefore, physicians should increasingly inform IBD patients about benefits and limitations of CAM treatment.
Similar articles
- Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
Quattropani C, Ausfeld B, Straumann A, Heer P, Seibold F. Quattropani C, et al. Scand J Gastroenterol. 2003 Mar;38(3):277-82. doi: 10.1080/00365520310000591a. Scand J Gastroenterol. 2003. PMID: 12737442 - Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.
Langhorst J, Anthonisen IB, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, Dobos GJ. Langhorst J, et al. Inflamm Bowel Dis. 2005 Mar;11(3):287-95. doi: 10.1097/01.mib.0000160771.71328.6c. Inflamm Bowel Dis. 2005. PMID: 15735435 - Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
Bauer N, Kairey L, Schlee C, Uecker C, Öznur Ö, Langhorst J. Bauer N, et al. Scand J Gastroenterol. 2022 Oct;57(10):1209-1215. doi: 10.1080/00365521.2022.2078667. Epub 2022 Jun 18. Scand J Gastroenterol. 2022. PMID: 35722930 - Complementary therapies in inflammatory bowel diseases.
Esters P, Dignass A. Esters P, et al. Curr Drug Targets. 2014;15(11):1079-88. doi: 10.2174/1389450115666140903112802. Curr Drug Targets. 2014. PMID: 25182607 Review. - Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.
Joos S. Joos S. Chin J Integr Med. 2011 Jun;17(6):403-9. doi: 10.1007/s11655-011-0758-3. Epub 2011 Jun 10. Chin J Integr Med. 2011. PMID: 21660673 Review.
Cited by
- Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri SP. Sengupta K, et al. Int J Med Sci. 2010 Nov 1;7(6):366-77. doi: 10.7150/ijms.7.366. Int J Med Sci. 2010. PMID: 21060724 Free PMC article. Clinical Trial. - Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.
Lippert A, Renner B. Lippert A, et al. J Clin Med. 2022 Mar 12;11(6):1567. doi: 10.3390/jcm11061567. J Clin Med. 2022. PMID: 35329893 Free PMC article. Review. - Probiotics in inflammatory bowel diseases and associated conditions.
Mack DR. Mack DR. Nutrients. 2011 Feb;3(2):245-64. doi: 10.3390/nu3020245. Epub 2011 Feb 17. Nutrients. 2011. PMID: 22254095 Free PMC article. Review. - Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.
Bhattacharjee N, Pathak S, Khuda-Bukhsh AR. Bhattacharjee N, et al. Evid Based Complement Alternat Med. 2009 Mar;6(1):65-75. doi: 10.1093/ecam/nem067. Epub 2007 Jun 19. Evid Based Complement Alternat Med. 2009. PMID: 18955221 Free PMC article. - Terpenes from Forests and Human Health.
Cho KS, Lim YR, Lee K, Lee J, Lee JH, Lee IS. Cho KS, et al. Toxicol Res. 2017 Apr;33(2):97-106. doi: 10.5487/TR.2017.33.2.097. Epub 2017 Apr 15. Toxicol Res. 2017. PMID: 28443180 Free PMC article. Review.
References
- Maskarinec G, Shumay DM, Kakai H, Gotay CC. Ethnic differences in complementary and alternative medicine use among cancer patients 8. J Altern Complement Med. 2000;6:531–538. - PubMed
- G M, S M. Gesundheitsberichterstattung des Bundes: Inanspruchnahme alternativer Methoden in der Medizin. Heft 9. Berlin; Germany, Robert Koch Institut, Statistisches Bundesamt; 2002. http://www.rki.de
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous